incubated with antibody at 37°C for 15 min in the presence or absence of fresh normal human serum. This was determined by fluorescence microscopy, using fluorescein-conjugated rabbit anti-L, pneumophila antiserum.
Capacity of PMN to Bind or to Ingest L. pneumophila. 5 × 106 PMN and 5 × 105 CFU of L. pneumophila were added to plastic tubes that contained 10% fresh normal human serum, 10% fresh immune human serum, or 10% heat-inactivated immune human serum. The tubes were brought to a final vol of 900/tl with HBSS, gassed with 5% CO2-95% air so that the pH was 7.4, as judged by the color of the phenol red indicator dye, capped, sealed with Parafilm (American Can Co., Greenwich, Conn.), and incubated for 30 min at 37°C on a gyratory shaker at 250 rpm. At the end of the incubation, the tubes were placed in an ice-water bath to stop the reaction, and the cells were centrifuged onto glass slides using a sealed cytocentrifuge specimen container especially designed for use with biohazardous material (Cytospin and Accessories, Shandron Southern Instruments, Inc., Sewickley, Pa.). The cells were fixed with Diff-Quick Fixative (Harleco, American Hospital Supply Corp., Gibbstown, N. J.), stained with fluorescein-conjugated rabbit anti-L, pneumophila antiserum as described (1) , and examined by fluorescence microscopy. The percentage of 200 consecutive PMN with associated bacteria, and the average number of bacteria/PMN were determined.
For electron microscopy, PMN and bacteria were incubated together at the same ratio and under the same conditions as described above. The cells were fixed and processed for electron microscopy essentially as described (1) except that they were centrifuged into 2% agarose before dehydration and embedding. The sections were stained with lead citrate and uranyl acetate (1) and examined with a Philips 300 electron microscope (Philips Electronic Instruments, Inc., Mahwah, N. J.).
PMN-killing Assay.
In all killing assays, reactants (total vol 900 p.l) were added sequentially to plastic tubes. The tubes were gassed with 5% CO2-95% air (final pH of contents of each tube --7.4), sealed, and incubated for 1, 2, or 3 h as described above under capacity of PMN to bind or ingest L. pneumophila. L. pneumophila (2.5 × 10 s or 5 X 10 s CFU) and/or E. coli (5 × 10 s CFU) in 100 p,I HBSS, the serum preparation (90 #1 fresh normal human serum, 90 #! fresh immune human serum, 90 #1 heat-inactivated immune human serum plus 90 #1 fresh normal human serum, or 4.5 #1 of dialyzed rabbit anti-L, pneumophila antiserum [8.5 agglutinating U/ml] plus 90 #1 fresh normal human serum) and enough PBS to bring the vol to 400 #1 were added first and incubated 10 min at 22°C. Then 2.5 or 5 X 106 PMN in 500 p,l HBSS (or the sonicate from an equivalent number of PMN or HBSS alone as controls) were added to each tube, after which the tubes were gassed, sealed, and incubated. A separate tube was used for each measurement; thus tubes were not opened until the end of the incubation. At that time, the tubes were placed in an ice-water bath to stop the reaction, and the contents were sonicated under sterile conditions for 15 sec continuously with a micro-tip attached to a sonicator (HeatSystems Ultrasonics, Inc., Plainview, N. Y.) set at the 3 position; this amount of energy was sufficient to lyse the PMN completely but did not reduce bacterial CFU (1, 2) . The CFU of L. pneumophila on CYE agar and ofE. coli on tryptic soy broth agar or CYE agar were determined as described (1, 2); E. coli grew equally well on both nutrient agars, but L. pneumophila grew only on CYE agar.
Separation of PMN-associated and Nonassociated L. pneumophila by Differential
Centrifugation. PMN and L. pneumophila were incubated with normal human serum or immune human serum as described above under PMN-killing assay. At the end of the incubation, 9.1 ml of PBS (4°C) was added to each tube, and the contents transferred to a conical centrifuge tube and centrifuged at 45 g for 10 rain at 4°C. When PMN were mixed with L. pneumophila at 4°C in medium that contained normal human serum and centrifuged under these conditions, >99% of PMN were pelleted but >99% of L. pneumophila remained in the supernate. The supernate was removed and the pellet was resuspended in 2 ml PBS. The supernate and resuspended pellet were then sonicated as described above under PMN-killing assay and the total CFU in the pellet and supernatant fractions determined. Three replicate tubes were used for each measurement with immune serum and two replicate tubes for each measurement with normal serum. Additional replicate tubes, the contents of which were not fractionated after the incubation, were used to measure killing ofL. pneumophila as in the PMN-killing assay described above; two tubes were used for each measurement.
Results

L. pneumophita Is Resistant to the Bactericidal Effects of Serum Even in the Presence of High
Concentrations of Antibody. We incubated 103-106 CFU/ml L. pneumophila in medium that contained various concentrations of fresh normal human serum (lacking antibody to L. pneumophila by the IFA assay) for 1 h at 37°C on a gyratory shaker. There was no reduction in CFU of L. pneumophila (Table I A) . Similarly, when we incubated L. pneumophila in medium that contained 0-50% fresh normal human serum and either 8.5 agglutinating U/ml of rabbit anti-L, pneumophila antiserum ( and complement was weak in comparison to that exhibited by a serum-resistant encapsulated strain of E. coli (E. coli 09:K29:H-) (2) . This suggests that the anti-L. pneumophila antibodies found in human immune serum or in rabbit antiserum are not capable of fixing as much C3 to the surface of L. pneumophila as human anti-E, coli antibodies are capable of fixing to the surface of the E. coli strain.
PMN Phagocytose L. pneumophila Only in the Presence of Both Antibody and Complement.
We incubated PMN with L. pneumophila in the presence of serum that contained anti-L, pneumophila antibody and/or complement. We then centrifuged the PMN onto glass slides, stained the PMN-associated bacteria with fluorescein-conjugated rabbit anti-L, pneumophila antiserum, and examined them by fluorescence microscopy (Table II) .
With complement alone or antibody alone, few PMN (21 and 14%, respectively) bound or ingested L. pneumophila, and those that did had an average of less than two bacteria/PMN (Table II) . With both antibody and complement, 93.5% of PMN bound or ingested L. pneumophila; these had an average of 5.1 L. pneumophila/PMN (Table II and L. pneumophila at the indicated concentrations of CFU/ml were incubated for 1 h at 37°C on a gyratory shaker in medium that contained 0, 10, 25, or 50% fresh normal human serum anc'l (A) No antibody, (B) 8.5 agglutinating doses/ ml of dialyzed rabbit anti-L, pneumophila antiserum, or (C) 20% heat-inactivated immune human serum with an IFA anti-L, pneumophila titer of 1:4,096. CFU were determined initially and at the end of the incubation.
in egg yolk-grown cultures [6] ). That PMN bound or ingested an average of 4.75 bacterial cells in the presence of antibody and complement (Table II) indicates that nearly all the bacterial cells in the culture were bound to or ingested by PMN under these conditions. That this conclusion is valid for viable bacteria is supported by our finding (Fig. 4 B) that nearly all the viable L. pneumophila in the culture are bound to or ingested by PMN in the presence of antibody and complement. were incubated in the presence of 10% of the indicated serum preparation for 30 rain at 37°C on a gyratory shaker. At the end of the incubation, the cells were cytocentrifuged on to glass slides, fixed, stained with fluorescein-conjugated rabbit anti-L, pneumophila antiserum, examined by fluorescence microscopy, and 20 consecutive PMN counted. (Table II) , most of the PMN-associated bacteria were intracellular. These results and our finding that antibody was required to fix complement to L.
pneumophila, indicate that PMN effectively phagocytose L. pneumophila only if complement is fixed to the bacterial surface.
PMN Require Both Antibody and Complement to Kill Any L. pneumophila.
We incubated PMN with L. pneumophila in the presence of fresh normal human serum, heatinactivated immune human serum (data not shown), or fresh immune human serum (Fig. 2) . PMN killed L. pneumophila only when both a source of antibody and of complement were present (Fig. 2) . Even then, PMN reduced CFU of L. pneumophila by only 0.5 log (70%) (five experiments). Increasing the ratio of PMN:L. pneumophila (Fig. 4 B) . Some additional killing occurred when the incubation was extended from 1 to 4 h (Fig. 4B ), but no additional killing occurred when the incubation was further extended from 4 to 6 h (data not shown).
L. pneumophila Resists Killing by PMN under Conditions in Which PMN Effectively Kill a Serum-resistant Encapsulated Strain orE. coli.
To compare PMN killing of L. pneumophila with PMN killing of a serum-resistant encapsulated strain of E. coli, we incubated PMN with E. coli alone, L. pneumophila alone, or both types of bacteria in the presence of fresh normal human serum with or without a source of rabbit or human anti-L.
pneumophila antibody (Fig. 3 ). In the experiment described in Fig. 3 , we used rabbit antiserum, but we o b t a i n e d similar results w h e n we used i m m u n e h u m a n serum. In the presence o f fresh n o r m a l s e r u m a n d a n t i b o d y , P M N failed to kill L. pneumophila effectively. U n d e r these s a m e conditions, P M N r e d u c e d C F U o f E. coli by 2.5 logs. ( P M N require b o t h a n t i b o d y a n d c o m p l e m e n t to kill E. coli [2] ; b o t h are present in fresh n o r m a l h u m a n serum, w h i c h contains low levels o f n a t u r a l a n t i b o d y against this strain o f E. coli [2] .) W h e n the E. coli a n d L. pneumophila were m i x e d t o g e t h e r in the s a m e test tube, P M N killed the E. coli as effectively as w h e n the E. coli were present alone, i n d i c a t i n g that the killing c a p a c i t y of P M N was not r e d u c e d in cultures c o n t a i n i n g L. pneumophila.
L. pneumophila Resists P M N Killing Even after the Bacteria are PMN-associated.
W h e n P M N are i n c u b a t e d w i t h L. pneumophila in the presence of a n t i b o d y a n d c o m p l e m e n t , they b i n d or ingest nearly all the bacterial cells (Table II) ; however, most of the 
Fio. 3. L. pneumophila resists killing by PMN under conditions in which PMN effectively kill a serum-resistant encapsulated strain of E. coli. PMN (2.5 × l0 n) and 5 × l0 b CFU of L. pneumophila and/or E. coli were incubated at 37°C for 1 h on a gyratory shaker in 0.9 ml medium (final volume) containing 10% fresh normal human serum (NS) alone or 10% NS plus 8.5 agglutinating units/ml of dialyzed rabbit anti-L, pneumophila antiserum (Aha-L.p.). CFU of E. coil and L. pneumophila were determined initially and at the end of the incubation.
bacterial cells from egg yolk-grown cultures are nonviable (6). Thus, from the studies described in Table II, we did Incubation time (h) pneumophila that occurred between 1 and 4 h after the start of the incubation appeared to result primarily from the death of PMN-associated bacteria. Thus, the resistance of opsonized L. pneumophila to PMN killing was a result of the failure of PMN to kill bacteria that were associated with them.
In contrast, when we incubated PMN and L. pneumophila together in the presence of only complement (fresh normal human serum) (Fig. 4 A) , nearly all (93%) of the CFU of L. pneumophila failed to associate with PMN and, as expected from previous results (Fig. 2) , PMN did not kill L. pneumophila under these conditions. Thus, the complete resistance of L. pneumophila to PMN killing in the absence of antibody was a result of a failure of PMN to bind these unopsonized bacteria.
PMN Do Not Support the Growth of L. pneumophila.
To determine whether PMN, like monocytes, support the growth of L. pneumophila (1, 7) , we incubated L. pneumophila with PMN in the presence of normal or immune serum on a gyratory shaker for 1 h, and without shaking thereafter, and determined CFU daily. L. pneumophila failed to multiply under either of these conditions.
Because PMN are relatively short-lived in comparison to monocytes, we repeated the experiment just described except we added fresh PMN and either normal or immune human serum to the cultures daily. After adding fresh cells and serum, we incubated the cultures on a gyratory shaker for 1 h and then returned them to stationary incubation for the remainder of the day. L. pneurnophila did not multiply under these conditions either.
Discussion
Our experiments show that virulent egg yolk-grown L. pneurnophila are completely resistant to the bactericidal effects of human serum even in the presence of high-titer rabbit or human anti-L, pneumophila antibody. In contrast, agar-adapted L. pneumophila have been reported to be sensitive to serum (8) . Egg yolk-grown and agar-adapted bacteria differ in that agar-adapted bacteria are avirulent for guinea pigs and eggs, whereas egg yolk-grown bacteria cause lethal infections in both. In their virulence, egg yolk-grown L. pneumophila more closely resemble a human pathogen than do agaradapted bacteria. Consequently, we suggest that L. pneumophila that are pathogenic for man are also serum resistant.
Antibody is required to fix complement to L. pneumophila and only complementcoated bacteria are efficiently bound to or ingested by PMN. In this respect, L. pneurnophila resembles encapsulated E. coli, an extracellular pathogen (2). The similarity ends here, however, because complement-coated E. coli are efficiently killed by PMN but complemented-coated L. pneumophila are not. A significant proportion of L. pneumophila resist killing by PMN even after the bacteria are bound to the PMN surface by phagocytosis-promoting ligands.
The capacity of L. pneumophila to resist completely killing by human serum and PMN in the absence of antibody likely contributes to its pathogenicity for man.
Because L. pneumophila are completely resistant to serum even in the presence of antibody, the degree to which antibody influences pathogenicity probably depends on how antibody affects the interaction of L. pneumophila with PMN and monocytes. In the case of PMN, the outcome of this interaction is inconclusive; some L. pneumophila are killed but a significant proportion survive the encounter. Consequently, the critical questions regarding the influence of antibody on pathogenicity may be whether antibody influences the interaction of L. pneumophila with monocytes and, especially, whether antibody alters the capacity of L. pneumophila to multiply within monocytes.
These questions are addressed in an accompanying paper (7).
Summary
We have previously reported that virulent egg yolk-grown Legionella pneumophila, Philadelphia 1 strain, multiplies intracellularly in human blood monocytes. We now report on the interaction between virulent L. pneumophila and human polymorphonuclear leukocytes (PMN), antibody, and complement, in vitro, under antibiotic-free conditions.
L. pneumophila in concentrations ranging from 103 to 106 colony forming units (CFU)/ml are completely resistant to the bactericidal effects of 0-50% fresh normal human serum, even in the presence of high concentrations of rabbit or human anti-L. pneumophila antibody. L. pneumophila bacteria fix the third component of complement (C3) to their surfaces, as measured by fluorescence microscopy using rhodamine-conjugated goat anti-human C3 IgG, only when the bacteria are incubated with both specific anti-L. pneumophila antibody and complement. Similarly, L. pneumophila adhere to PMN, as measured by fluorescence microscopy, only in the presence of both specific antibody and complement. Electron microscopy revealed that these opsonized bacteria are phagocytosed by the PMN. PMN require both antibody and complement to kill L. pneumophila; even then, PMN reduced CFU of L. pneumophila by only 0.5 log under conditions in which they reduce CFU of a serum-resistant encapsulated strain of Escherichia coli by 2.5 logs. Separation of PMN-associated and nonassociated CFU of L. pneumophila revealed that the major proportion of the surviving bacteria are PMN associated. Thus, the ineffective killing of opsonized L. pneumophila is a result of a failure of PMN to kill these bacteria after they become PMN-associated. With or without antibody, PMN do not support the growth of L. pneumophila.
These findings suggest that PMN, even in conjunction with the humoral immune system, do not play a decisive role in defense against the Legionnaires' disease bacterium.
